Aetna Enters China’s Health Insurance Market
This article was originally published in PharmAsia News
After receiving approval from the China Insurance Regulatory Commission last March, U.S. health insurance giant Aetna has announced it will set up its representative office in Shanghai. This marks its entry into the country, paving the way for its application for an insurance business license two years later. Capitalizing on its international standards and knowledge of the China market, Aetna will be able to provide full health insurance services to local enterprises as well as MNCs with branches in the Far East. (Click here for more - Chinese Language)
You may also be interested in...
The proposed rule from the US HHS that would require its agencies to review all regulations every 10 years could distract an incoming Biden administration from the COVID-19 pandemic and will “wreak havoc” on Medicare, a senior policy analyst for the Center on Budget and Policy Priorities says.
The pharmacy will be ready to begin COVID-19 vaccinations 48 hours after receiving the vaccine, Merlo said, outlining plans for a mass vaccination effort that will include online appointments.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.